Pre-clinical heterotopic intrathoracic heart xenotransplantation: A possibly useful clinical technique

Jan Michael Abicht, Tanja Mayr, Bruno Reichart, Stefan Buchholz, Fabian Werner, Isabelle Lutzmann, Michael Schmoeckel, Andreas Bauer, Michael Thormann, Martin Langenmayer, Nadja Herbach, Heike Pohla, Rudolf Herzog, Christopher G.A. McGregor, David Ayares, Eckhard Wolf, Nikolai Klymiuk, Andrea Baehr, Alexander Kind, Christian HaglUte Ganswindt, Claus Belka, Sonja Guethoff, Paolo Brenner

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


Background As a step towards clinical cardiac xenotransplantation, our experimental heterotopic intrathoracic xenotransplantation model offers a beating and ejecting donor heart while retaining the recipient′s native organ as a backup in case of graft failure. Clinically applicable immunosuppressive regimens (IS) were investigated first, then treatments known to be effective in hypersensitized patients or those with recalcitrant rejection reactions. Methods Consecutive experiments were carried out between 2009 and 2013. Twenty-one genetically modified pigs (GGTA1-knockout/hCD46/± thrombomodulin, in one case HLA-E instead) were used as donors. In all experiments, two cycles of immunoabsorption reduced preformed antibodies. Recipient baboons were divided into two groups according to IS regimen: In group one (n = 10), pre-treatment started either one (anti-CD20) or four weeks (anti-CD20 plus the proteasome inhibitor bortezomib) prior to transplantation. The extended conventional (as for allotransplantation) immunosuppressive maintenance regimen included anti-thymocyte globuline, tacrolimus, mycophenolate mofetil, methylprednisolone and weekly anti-CD20. In group two (n = 11), myeloablative pre-treatment as in multiple myeloma patients (long and short regimens) was added to extended conventional IS; postoperative total thoracic and abdominal lymphoid irradiation (TLI; single dose of 600 cGY) was used to further reduce antibody-producing cells. Results In the perioperative course, the surgical technique was safely applied: 19 baboons were weaned off extracorporeal circulation and 17 extubated. Nine animals were lost in the early postoperative course due to causes unrelated to surgical technique or IS regimen. Excluding these early failures, median graft survival times of group 1 and 2 were 18.5 (12-50) days and 16 (7-35) days. Necropsy examination of group 1 donor organs revealed hypertrophy of the left ventricular wall in the six longer-lasting grafts; myocardial histology confirmed pre-clinical suspicion of humoral rejection, which was not inhibited by the extended conventional IS including intensified treatments, and signs of thrombotic microangiopathy. Grafts of group 2 presented with only mild-to-moderate features of humoral rejection and thrombotic microangiopathy, except in one case of delayed rejection on day 17. The other experiments in this group were terminated because of untreatable pulmonary oedema, recurring ventricular fibrillation, Aspergillus sepsis, as well as a combination of a large donor organ and late toxic side effects due to TLI. Conclusions Longer-term results were difficult to achieve in this model due to the IS regimens used. However, we conclude that heterotopic intrathoracic heart transplantation may be an option for clinical xenotransplantation.

Original languageEnglish (US)
Pages (from-to)427-442
Number of pages16
Issue number6
StatePublished - Nov 1 2015
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2015 The Authors. Xenotransplantation Published by John Wiley & Sons Ltd.


  • heart transplantation
  • heterotopic
  • intrathoracic
  • pre-clinical
  • total thoracic and abdominal lymphoid irradiation
  • xenotransplantation


Dive into the research topics of 'Pre-clinical heterotopic intrathoracic heart xenotransplantation: A possibly useful clinical technique'. Together they form a unique fingerprint.

Cite this